The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis

The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis

Abstract Background The Multi-System Inflammatory Syndrome in Children (MIS-C) can develop several weeks after SARS-CoV-2 infection and requires a distinct treatment protocol. Distinguishing MIS-C from SARS-CoV-2 negative sepsis (SCNS) patients is important to quickly institute the correct therapies...

Full description

Bibliographic Details
Main Authors: Maitray A. Patel, Douglas D. Fraser, Mark Daley, Gediminas Cepinskas, Noemi Veraldi, Serge Grazioli
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Molecular Medicine
Subjects:
MIS-C
Sepsis
Targeted proteomics
Machine learning
Biomarker discovery
Online Access:https://doi.org/10.1186/s10020-024-00806-x

Internet

https://doi.org/10.1186/s10020-024-00806-x

Similar Items